The Wegovy pill comes in tablet form—and is the first U.S. Food & Drug Administration (FDA)-approved GLP-1 to do so. Its ...

MNT speaks with three obesity medicine experts to find out more about the FDA-aproved Wegovy pill and how it's different from ...

The post Oral GLP-1 Obesity Drugs Near Wider Access appeared first on Considerable.

There are two drugs on the market - semaglutide, marketed under the brand name Wegovy, and tirzepatide, sold as Mounjaro.

People taking weight-loss drugs are likely to regain the weight they have lost within two years of stopping the medications, ...

SAN FRANCISCO, Jan 12 () - Amgen's research chief said the company is very confident about its experimental obesity drug ...

The new oral drug costs as little as $149 a month out of pocket and is expected to broaden access as demand for GLP-1 ...

In this week’s Medical Minute, Dr. Lacey Anderson said the first oral GLP-1 medication for weight loss, a pill version of ...

Long-defined by high prices, shortages and weekly injections, weight loss drugs including Wegovy and Zepbound are expected to ...

Researchers found weight returns far faster after stopping GLP-1 drugs than after diet or exercise programmes On average, ...

Health system pharmacists and clinicians are monitoring a wave of drug approvals expected throughout 2026, including first-in-class therapies and expanded uses of existing drugs with implications for ...